Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Basic) (2022 - 2025)

Praxis Precision Medicines has reported EPS (Basic) over the past 4 years, most recently at -$3.51 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 17.0% year-over-year to -$3.51; the TTM value through Dec 2025 reached -$13.47, down 30.4%, while the annual FY2025 figure was -$13.48, 32.03% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$3.51 at Praxis Precision Medicines, down from -$3.36 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.96 in Q3 2022 and troughed at -$65.86 in Q4 2022.
  • A 4-year average of -$7.26 and a median of -$2.92 in 2024 define the central range for EPS (Basic).
  • On a YoY basis, EPS (Basic) climbed as much as 97.02% in 2023 and fell as far as 600.66% in 2023.
  • Year by year, EPS (Basic) stood at -$65.86 in 2022, then skyrocketed by 97.02% to -$1.96 in 2023, then tumbled by 53.06% to -$3.0 in 2024, then decreased by 17.0% to -$3.51 in 2025.
  • Business Quant data shows EPS (Basic) for PRAX at -$3.51 in Q4 2025, -$3.36 in Q3 2025, and -$3.31 in Q2 2025.